secwatch.observer — SEC 8-K summary
======================================

Issuer:     IBEX Ltd (IBEX)
CIK:        0001720420
Form:       8-K
Filed at:   2026-02-05T23:59:59+00:00
Accession:  0001720420-26-000005
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IBEX reports record Q2 revenue $164.2M (+17% YoY), raises FY revenue & EBITDA guidance
--------------------------------------------------------------------------------

- Q2 revenue $164.2M (+16.7% YoY); net income $12.2M; diluted EPS $0.83 (+45% YoY).
- Adjusted EBITDA $20.7M (+25.2% YoY); adjusted EPS $0.87 (+46% YoY).
- Raises FY2026 revenue guidance to $620-630M (from $605-620M) and adjusted EBITDA to $80-82M (from $78-81M).
- HealthTech revenue grew 35.1% YoY; repurchased 78,200 shares for $2.9M during quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1720420/000172042026000005/0001720420-26-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1720420/000172042026000005/ibex-20260205.htm
  HTML page:      https://secwatch.observer/filing/0001720420-26-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer